• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Cell Mol Med . Identification of key candidate biomarkers for severe influenza infection by integrated bioinformatical analysis and initial clini

tetano

Editor, Senior Moderator
J Cell Mol Med


. 2021 Jan 14.
doi: 10.1111/jcmm.16275. Online ahead of print.
Identification of key candidate biomarkers for severe influenza infection by integrated bioinformatical analysis and initial clinical validation


Shuai Liu[SUP] 1 2 [/SUP], Zhisheng Huang[SUP] 2 3 [/SUP], Xiaoyan Deng[SUP] 4 [/SUP], Xiaohui Zou[SUP] 1 2 3 [/SUP], Hui Li[SUP] 1 2 3 [/SUP], Shengrui Mu[SUP] 1 2 [/SUP], Bin Cao[SUP] 1 2 3 4 [/SUP]



Affiliations

Abstract

One of the key barriers for early identification and intervention of severe influenza cases is a lack of reliable immunologic indicators. In this study, we utilized differentially expressed genes screening incorporating weighted gene co-expression network analysis in one eligible influenza GEO data set (GSE111368) to identify hub genes associated with clinical severity. A total of 10 genes (PBI, MMP8, TCN1, RETN, OLFM4, ELANE, LTF, LCN2, DEFA4 and HP) were identified. Gene set enrichment analysis (GSEA) for single hub gene revealed that these genes had a close association with antimicrobial response and neutrophils activity. To further evaluate these genes' ability for diagnosis/prognosis of disease developments, we adopted double validation with (a) another new independent data set (GSE101702); and (b) plasma samples collected from hospitalized influenza patients. We found that 10 hub genes presented highly correlation with disease severity. In particular, BPI and MMP8 encoding proteins in plasma achieved higher expression in severe and dead cases, which indicated an adverse disease development and suggested a frustrating prognosis. These findings provide new insight into severe influenza pathogenesis and identify two significant candidate genes that were superior to the conventional clinical indicators. These candidate genes or encoding proteins could be biomarker for clinical diagnosis and therapeutic targets for severe influenza infection.

Keywords: differentially expressed genes; hub genes; network analysis; neutrophils; severe influenza; weighted gene co-expression network analysis.
 
Back
Top Bottom